-
After randomized controlled trials demonstrated the benefit of daily sedation and analgesia vacations in critically ill patients, sedation and analgesia practices in many centers changed, such that patients are now maintained at a lighter depth of sedation.
-
After identifying the first 2 cases of novel influenza (H1N1) infection in the United States in mid-April 2009, the Centers for Disease Control and Prevention (CDC) provided interim recommendations to reduce the risk of transmission in health care settings.
-
Nassar and colleagues at the University of São Paulo in Brazil investigated the incidence, associations, and outcomes of constipation among all patients admitted to their 14-bed surgical ICU during a 6-month period.
-
Levin and colleagues at Hebrew University-Hadassah Medical School in Jerusalem carried out a 4-phase study to clarify the role of radiology technicians and portable X-ray equipment as potential vectors for the spread of infection in their 20-bed ICU, as well as to determine whether an intervention designed to diminish this role would be effective.
-
In this issue: WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.
-
-
-
The FDA has approved a single-dose formulation of Plan B, the emergency contraceptive previously available in a two-tablet dose.
-
Two papers presented at the recent American Society of Clinical Oncology (ASCO) have brought to light to potential serious drug interaction between tamoxifen and several commonly used SSRI antidepressants.
-
The FDA has approved prasugrel, a new oral antiplatelet agent for use in preventing thrombosis in patients with acute coronary syndrome who are to be managed by angioplasty.
